| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/25/2008 | US20080233122 Complementarity determining regions; immunoglobulins; cell line, host cells; transgenic animals, plants |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233117 Reducing tumor growth |
| 09/25/2008 | US20080233116 Human monoclonal antibodies to CTLA-4 |
| 09/25/2008 | US20080233111 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection |
| 09/25/2008 | US20080233107 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide |
| 09/25/2008 | US20080233097 different phosphorylation site is the threonine residue in position 123 (Thr123) of mouse or human p38, alpha isoform; diagnostic marker of pathologies mediated by MAPKs |
| 09/25/2008 | US20080233091 use of a live culture of a non-pathogenic food-grade probiotic bacterium ( lactococcus or lactobacillus strains of lactic acid bacteria) in the treatment of infectious diseases, may be a localised infection of the skin, including an infected wound, a urinary tract infection or mastitis |
| 09/25/2008 | US20080233090 Method of Treatment by Administration of Rna |
| 09/25/2008 | US20080233086 Expression Vectors for Treating Bacterial Infections |
| 09/25/2008 | US20080233059 Heating and reacting polyglycerol with ricinoleic acid or another hydroxyl fatty acid to polymerize; maintaining temperature until reaction mixture reaches a desired acid value; esterification, condensation polymerization, catalysis with acid or basic catalyst; cosmetics, sunscreen agents, dairy products |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/25/2008 | CA2653226A1 Liposomes and immunopotentiating compositions containing the same |
| 09/24/2008 | EP1972615A1 Cycloalkanecarboxamide derivative and method for producing same |
| 09/24/2008 | EP1972341A1 Pharmaceutical compositions comprising a bisphosphonate and vitamin D |
| 09/24/2008 | EP1972338A1 Anti-infective agents |
| 09/24/2008 | EP1971341A1 Use of morpholino compounds for the treatment of halitosis |
| 09/24/2008 | EP1885725B1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 09/24/2008 | EP1809615A4 Lamotrigine analogs |
| 09/24/2008 | EP1585509B1 Sphingolipids for improvement of the composition of the intestinal flora |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/24/2008 | EP1496836B1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 09/24/2008 | EP1438031B1 Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | EP1383578B1 Single dose aromatase inhibitor for treating infertility |
| 09/24/2008 | EP1365762B1 Method for increasing leptin levels using nicotinic acid compounds |
| 09/24/2008 | EP1341535B1 Skin whiteners containing hydroxytetronic acid |
| 09/24/2008 | EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 09/24/2008 | EP1254658B1 Remedies for the treatment of nerve diorders |
| 09/24/2008 | EP1027040B1 Use of mitoguazone dihydrochloride for treating macrophage-associated diseases |
| 09/24/2008 | CN101272806A 过早排卵抑制剂 Premature ovulation inhibitors |
| 09/24/2008 | CN101272803A Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink |
| 09/24/2008 | CN101270362A Novel serine protease genes related to DPPIV |
| 09/24/2008 | CN101269214A Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 09/24/2008 | CN101268862A Method for preparing gingkgo health care cigarette |
| 09/24/2008 | CN101268844A Healthcare pheasant Soup and preparing technique |
| 09/24/2008 | CN100420945C Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures |
| 09/24/2008 | CN100420672C Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/24/2008 | CN100420440C Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427668 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 09/23/2008 | US7427660 Tumor antigen |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427628 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
| 09/23/2008 | US7427627 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427619 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427395 a Sendai virus envelope vector incorporated with anticancer or antitumor agents |
| 09/23/2008 | CA2480800C Inhibitors of akt activity |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2416169C Compositions containing therapeutically active components having enhanced solubility |
| 09/23/2008 | CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
| 09/23/2008 | CA2372992C Selenium-containing pro-drugs for cancer therapy |
| 09/23/2008 | CA2338256C Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 09/23/2008 | CA2336833C Remedy with antidepressant effects |
| 09/23/2008 | CA2332126C A novel human thrombopoietin mutein |
| 09/23/2008 | CA2293373C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 09/23/2008 | CA2206008C Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 09/23/2008 | CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 09/23/2008 | CA2118373C Method to reverse the phenotype of transformed cells by the transcription factor irf-1 |
| 09/18/2008 | WO2008113051A2 System for treating addictions |
| 09/18/2008 | WO2008112987A1 Treating skin cancer |
| 09/18/2008 | WO2008111832A1 Method of improving skills with a composition comprising non-digestible saccharide |
| 09/18/2008 | WO2008111604A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |
| 09/18/2008 | WO2008111597A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111503A1 Protective agent for transplanted organ |
| 09/18/2008 | WO2008111473A1 Glucokinase activator |
| 09/18/2008 | WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/18/2008 | WO2008111441A1 Pharmaceutical composition |
| 09/18/2008 | WO2008111295A1 Agent for prevention and/or treatment of systemic lupus erythematosus |
| 09/18/2008 | WO2008111244A1 External preparation for skin, and food |
| 09/18/2008 | WO2008110034A1 3-hydroxy fatty acid and its derivatives for improving of learning and/or memory of subjects |
| 09/18/2008 | WO2007104933A8 Chemical compounds |
| 09/18/2008 | US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 09/18/2008 | US20080227850 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 09/18/2008 | US20080227845 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 09/18/2008 | US20080227844 evaluating bucindolol treatment for patient with heart failure; whether to administer bucindolol based on if the patient is homozygous for the Arg 389 polymorphism in the .beta.1-adrenergic receptor; bucindolol not indicated wherein the patient is a Del322-325 carrier in alpha2cAR; pharmacogenetics |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227801 Pharmaceutical Compositions Containing Erythrina Mulungu Derivatives, Processes for their Production and Uses Thereof |
| 09/18/2008 | US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride |
| 09/18/2008 | US20080227784 5-chloro-N-(3-fluoro-4-morpholinophenyl)-2-hydroxybenzamide; prophylactic and/or therapeutic treatment of diseases caused by an activation of STAT6 and/or NF- kappa B |
| 09/18/2008 | US20080227770 Benzoxazepine Compound |
| 09/18/2008 | US20080227750 Complex of glycan and galactin accumulated on cell surfaces; therapy, prevention of autoimmune diseases |
| 09/18/2008 | US20080227742 Photocleavable oligonucleotide and uses thereof |
| 09/18/2008 | US20080227738 Compositions and methods for cell dedifferentiation and tissue regeneration |